KR0173436B1 - Silkworm bioactivity regulator - Google Patents

Silkworm bioactivity regulator Download PDF

Info

Publication number
KR0173436B1
KR0173436B1 KR1019950010135A KR19950010135A KR0173436B1 KR 0173436 B1 KR0173436 B1 KR 0173436B1 KR 1019950010135 A KR1019950010135 A KR 1019950010135A KR 19950010135 A KR19950010135 A KR 19950010135A KR 0173436 B1 KR0173436 B1 KR 0173436B1
Authority
KR
South Korea
Prior art keywords
compound
silkworms
dimethyl
formula
present
Prior art date
Application number
KR1019950010135A
Other languages
Korean (ko)
Other versions
KR960037661A (en
Inventor
강석구
설광열
Original Assignee
김광희
농촌진흥청
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김광희, 농촌진흥청 filed Critical 김광희
Priority to KR1019950010135A priority Critical patent/KR0173436B1/en
Publication of KR960037661A publication Critical patent/KR960037661A/en
Application granted granted Critical
Publication of KR0173436B1 publication Critical patent/KR0173436B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/501,3-Diazoles; Hydrogenated 1,3-diazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

본 발명은 신규한 1-(4-플루오로벤질)-5-[(E) 또는 (Z)-2,6-디메틸-1,5-헵타디에닐] 이미다졸 화합물, 및 그의 제조방법, 그를 함유하는 누에의 생리활성 조절 조성물 및 누에의 생리활성 조절 방법을 제공한다.The present invention provides a novel 1- (4-fluorobenzyl) -5-[(E) or (Z) -2,6-dimethyl-1,5-heptadienyl] imidazole compound, and a process for preparing the same, Provided are a physiological activity regulating composition of silkworms containing and a method of controlling physiological activity of silkworms.

상기 본 발명의 화합물은 종래의 화합물들과는 달리(E)형태와(Z)형태가 모두 누에의 3면화(眠化)를 유도할 수 있는 생리활성을 갖기 때문에 이들을 서로 분리할 필요가 없어 제조방법이 간단하고, 나아가 종래 화합물에 비해 생리활성이 높다.Unlike the conventional compounds, the compounds of the present invention do not need to be separated from each other because the (E) and (Z) forms all have a physiological activity that can induce tricotylation of silkworms. It is simple and furthermore has higher physiological activity as compared with the conventional compound.

Description

[발명의 명칭][Name of invention]

누에 생리활성 조정제Silkworm bioactive modulator

[발명의 상세한 설명]Detailed description of the invention

본 발명은 누에의 생리활성을 변화시켜 조기변태를 유도하여 3면화(3眠化)시키는 신규 화합물, 이의 제조방법 및 이를 이용하여 누에를 조기변태시켜 3면화하는 방법에 관한 것이다.The present invention relates to a novel compound that changes the physiological activity of silkworms to induce premature transformation and trilates (3 (化), a preparation method thereof, and a method of trimodating silkworms by premature transformation using the same.

누에는 보통 4면(眠)을 하지만, 약령(若齡)유충을 조숙 성충화시키는 항유약(抗幼若)호르몬 활성물질을 처리하면 조기 변태(早熱變態)를 유도하여 3면화(眠化)되어 4령 7-8일째에 토사(吐絲)하여 고치를 짓는다.Silkworms usually have four sides, but treatment with anti-glaze hormone actives that prematurely ages larvae induces premature metamorphosis, resulting in tricotylation. Then, they dig up the cocoons on the seventh and eighth days of the fourth year.

4면잠(4眠蠶)인 일반 누에가 생산하는 고치 실의 굵기가 보통 3데니어(d)정도인데 반하여, 항유약 호르몬 활성물질을 처리해서 생산되는 고치로부터는 양질의 세섬도 견사(약 2d 이하)를 얻을 수 있다.Although the thickness of cocoon thread produced by the common silkworm (4 면) is about 3 denier (d), high-quality fine silk thread is produced from cocoons produced by treating anti-glaze hormone active material (about 2d or less). ) Can be obtained.

종래 누에의 3면화를 유도하기 위하여 사용된 화합물은 일본 큐슈 대학교 농과대학의 E. Kuwano, R. Takeya 및 Mo. Eto에 의해 개발된 1-벤질-5[(E)-2,6-디메틸-1,5-헵타디에틸)] 이미다졸(일명 KK-42)로서 이 화합물은 누에 데 대한 항 유약 효과가 크며 다른 곤충들에게도 활성을 나타내고 있고 앞으로 실용화될 전망이다.Conventional compounds used to induce tricotton of silkworms are E. Kuwano, R. Takeya and Mo. 1-benzyl-5 [(E) -2,6-dimethyl-1,5-heptadiethyl)] imidazole (KK-42) developed by Eto, which has a high antiglaze effect against silkworms. It is also active in other insects and is expected to be used in the future.

그러나, 이 화합물은 100% 3면화를 유도할 수는 있지만, 3면화를 유도하는데 필요한 최저농도는 20㎍이고, 합성에 있어서 수율이 20%에 머무르며 기하이성체중(E)체만이 생물활성을 갖기 때문에 분리공정이 복잡하고 생산비가 매우 고가인 문제점이 있다.However, although the compound can induce 100% tri-cotton, the minimum concentration required to induce tri-cotton is 20 µg, the yield remains 20% in synthesis, and only geometric isomers (E) have bioactivity. Because of this complex separation process and production costs are very expensive.

이에 본 발명자들은 공지의 화합물보다 적은 양으로 누에는 3면화를 유도할 수 있고(즉, 생물활성이 높고), 기하이성체중(E)체 및 (Z)체가 모두 활성을 갖기 때문에 매우 까다롭고도 복잡한 이성체 분리공정을 생략할 수 있는 누에의 새로운 3면화 유도제를 제공하고자 하는 목적으로 광범위하게 연구를 행하였다.The present inventors can induce silkworm tricotyl in lesser amounts than known compounds (ie, have high bioactivity) and are very demanding because both geometric isomers (E) and (Z) are active. Extensive research has been conducted with the aim of providing a novel tri-cotton inducer for silkworms that can omit complex isomer separation processes.

그 결과로서 항유약 호르몬 활성을 갖는 이미다졸(imidazol)계 화합물중 1-(4-플루오로벤질)-5-[(E) 또는 (Z)-2,6-디메틸-1,5-헵타디에닐]이미다졸에 위해 상기 목적을 달성할 수 있음을 발견하고 본 발명을 완성하기에 이르렀다.As a result, 1- (4-fluorobenzyl) -5-[(E) or (Z) -2,6-dimethyl-1,5-heptadiee in imidazol compounds having antiglaze hormone activity It has been found that the above object can be achieved for nil] imidazole and the present invention has been completed.

즉, 본 발명의 목적은 하기 일반식(1A)와 (1B)로 표시되는 신규한 이미다졸계 화합물을 제공하는 것이다.That is, an object of the present invention is to provide a novel imidazole compound represented by the following general formulas (1A) and (1B).

본 발명의 다른 목적은 하기 일반식(3)의 화합물과 하기 일반식(4)의 화합물을 반응시켜 하기 일반식(5)의 화합물을 수득하고, 이어 일반식(5)의 화합물을 하기 일반식(2)의 화합물과 반응시켜 하기 일반식(1A)의 화합물(E-형태)과 하기 일반식(1B)의 화합물(Z-형태)의 혼합물의 형태로서 1-(4-플루오로벤질)-5-[2,6-디메틸-1,5-헵타디에닐] 이미다졸을 수득함을 특징으로 하는 1-(4-플루오로벤질)5-[(E) 또는 (Z)-2,6-디메틸-1,5-헵타디에닐] 이미다졸의 제조방법을 제공한다.Another object of the present invention is to react a compound of formula (3) with a compound of formula (4) to obtain a compound of formula (5), followed by compound of formula (5) 1- (4-fluorobenzyl)-in the form of a mixture of the compound (E-form) of the following general formula (1A) and the compound (Z-form) of the following general formula (1B) by reacting with the compound of (2) 1- (4-fluorobenzyl) 5-[(E) or (Z) -2,6- characterized by obtaining 5- [2,6-dimethyl-1,5-heptadienyl] imidazole Dimethyl-1,5-heptadienyl] imidazole is provided.

본 발명은 또한 상기 화합물 (1A), (1B)또는 (1A)와 (1B)와의 혼합물을 이용하여 누에를 효과적으로 조기변태시켜 3면화시키는 방법을 제공하는 것이다.The present invention also provides a method of effectively prematurely transforming silkworms by using the compound (1A), (1B) or a mixture of (1A) and (1B) to trilate the silkworm.

본 발명의 다른 목적 및 특징, 그리고 적용은 하기 발명의 상세한 설명으로부터 당업자에게 명백하게 드러날 것이다.Other objects, features, and applications of the present invention will become apparent to those skilled in the art from the following detailed description.

이하 본 발명을 보다 상세히 설명한다.Hereinafter, the present invention will be described in more detail.

본 발명에 따라 제공되는 1-(4-플루오로벤질)-5-[(E) 또는 (Z)-2,6-디메틸-1,5-헵타디에닐] 이미다졸을 이용하여 누에를 처리하면 거의 100% 3면화를 유도하여 평균 1.75d정도의 세섬도(細纖度) 고치실을 대량 생산할 수 있다.Treatment of silkworms using 1- (4-fluorobenzyl) -5-[(E) or (Z) -2,6-dimethyl-1,5-heptadienyl] imidazole provided according to the invention It can induce almost 100% 3 cotton, and can mass produce fine fine cocoon thread of average 1.75d.

본 발명의 방법에 따라 얻어지는 (Z)체(일반식 1A 화합물)와 (E)체(일반식 1B 화합물)의 비율은 100 : 약 85-90의 범위내에 있다. 이들 기하 이성체 모두 생물활성을 갖기 때문에 이들을 분리할 필요가 없고 따라서 복잡한 분리공정을 생략할 수 있는 장점이 있을 뿐만 아니라 이들 모두 생물활성이 공지의 화합물보다 높은 장점이 있다.The ratio of the (Z) (formula 1A compound) and (E) (formula 1B compound) obtained by the method of the present invention is in the range of 100: about 85-90. Since all of these geometric isomers have biological activity, there is no need to separate them, and thus, there is an advantage that a complicated separation process can be omitted, and all of them have a higher biological activity than known compounds.

본 발명의 1-(4-플루오로벤질)-5-[(E) 또는 (Z)-2,6-디메틸-1,5-헵타디에닐] 이미다졸은 누에의 3면화를 유도하기 위하여 경구 또는 경피 투여 등의 각종의 방법으로 누에에게 투여될 수 있지만, 바람직하게는 경구 투여된다.1- (4-Fluorobenzyl) -5-[(E) or (Z) -2,6-dimethyl-1,5-heptadienyl] imidazole of the present invention can be used orally to induce tricotization of silkworms. Alternatively, the silkworm may be administered to the silkworm by various methods such as transdermal administration, but is preferably administered orally.

그리고, 경구 투여의 목적을 위하여 수화제의 형태로 제제화되어 사용될 수 있으며, 제제중의 본 발명의 화합물의 농도는 약 20중량%일 수 있다. 제제 중에 포함되는 기타 부형제의 종류와 양은 당업계에 공지되어 있으며, 당업자가 용이하게 결정할 수 있다.In addition, it may be formulated and used in the form of a hydrating agent for the purpose of oral administration, and the concentration of the compound of the present invention in the preparation may be about 20% by weight. The types and amounts of other excipients included in the formulation are known in the art and can be readily determined by one skilled in the art.

한편, 제제화된 1-(4-플루오로벤질)-5-[(E) 또는 (Z)-2,6-디메틸-1,5-헵타디에닐] 이미다졸의 수화제의 경구(첨식)처리 방법은 특별히 한정되지 않지만, 누에 상자당 3령 기잠에 500배액 2ℓ를 순뽕 7kg에 분무 처리한 후 약간 물기를 말린 후 1일 3회 뽕을 주는 시간에 나누어 주는 것이 바람직하다. 이렇게 하면 사육 노동력이 가장 많이 필요한 5령 후반부에 해당하는 시기가 없어지므로 양잠 노동력의 약 50%가 감소되고 뽕잎 소요도 40% 정도 줄게 되므로 같은 면적의 뽕밭에서 약 1.8배량의 소잠이 가능하여 생산 양잠농가의 소득이 증대될 수 있으며 생산된 고치실은 1.75d정도의 세섬도이기 때문에 견제품의 부가가치를 제고할 수 있으며 하이브리드 실크(hybrid silk) 제조 등에 응용될 수 있어 실크의 용도 다양화를 꾀할 수 있어 실크산업의 국제 경쟁력을 강화할 수 있을 것으로 전망된다.On the other hand, oral (feeding) treatment method of the hydrating agent of formulated 1- (4-fluorobenzyl) -5-[(E) or (Z) -2,6-dimethyl-1,5-heptadienyl] imidazole Although not particularly limited, it is preferable to spray 2 liters of 500 times 2 liters of silkworms per three-month-long silkworm box, and then spray it on 7 kg of pure mulberry, and then dry it a little and divide it at the time of giving the mulberry three times a day. This eliminates the period corresponding to the latter part of the 5th age, which requires the most labor for breeding labor, which reduces about 50% of the labor force and reduces the mulberry leaf requirements by 40%, thus allowing 1.8 times the amount of sleep in the mulberry field of the same area. The income of farmers can be increased, and the produced cocoon is 1.75d fineness, which can enhance the added value of silk products and can be applied to the production of hybrid silk. The international competitiveness of the silk industry is expected to be strengthened.

한편, 본 발명의 방법에 따라 화합물 (1A)와 (1B)를 제조하는 공정은 다음과 같다 : 하기 공정도에서 알수 있는 바와 같이 먼저 토실메틸 이소시아나이드(TOSMIC)를 제조하고, 이를 이용하여 화합물 (1A)와 (1B)를 제조한다.Meanwhile, the process for preparing compounds (1A) and (1B) according to the method of the present invention is as follows: First, tosylmethyl isocyanide (TOSMIC) is prepared, and the compound ( 1A) and 1B are prepared.

이하 실시예를 통하여 본 발명을 보다 상세히 설명하지만 본 발명이 이들 예에만 국한되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to the following examples, but the present invention is not limited to these examples.

[실시예 1]Example 1

[토실메틸 이소시아나이드(TOSMIC)(2)의 제조][Production of tosylmethyl isocyanide (TOSMIC) (2)]

TOSMIC합성에 필요한 시약은 파라톨루엔산나트륨, 포름산, 포름산아미드와 POCl3등이며, 본 실시예에서 얻어진 TOSMIC은 하기 실시예 2에서처럼 시트랄과 파라플루오르벤질아민, t-부틸아민을 이용한 일련의 반응에 사용되며, 한단계 반응에 의해 (1A)와 (1B)의 비가 100:87인 혼합물을 얻을 수 있다. 이때의 수율은 81%이며, 위치자리 이성체를 분리하지 않아도 되는 큰 장점이 있다.Reagents required for TOSMIC synthesis are sodium paratoluate, formic acid, formic acid amide and POCl 3 , and TOSMIC obtained in this example is a series of reactions using citral, parafluorobenzylamine and t-butylamine, as in Example 2 below. It is used in, and a single step reaction gives a mixture having a ratio of (1A) and (1B) of 100: 87. The yield at this time is 81%, there is a big advantage that does not need to separate the positional isomers.

p-TsNa(26.7g, 0.15mol), 75㎖ 증류수, 35% 포름알데히드(35㎖, 0.44mol), 포름아미드(60㎖, 1.5㎖), 포름산(24g, 0.53mol)을 90℃에서 두시간 가열한다.p-TsNa (26.7g, 0.15mol), 75ml distilled water, 35% formaldehyde (35ml, 0.44mol), formamide (60ml, 1.5ml), formic acid (24g, 0.53mol) heated at 90 ° C for 2 hours do.

이를 냉각하고 얼음조에서 저은 다음 -20℃에서 밤새 방치한다. 흰 고체를 물로 여러번 씻고 흰 고체(mp 106-110℃, 45%, 14g)를 얻는다. 얻어진 토실메틸포름아미드(10.7g, 0.05mol), 25㎖ DME, 10㎖ 에테르, 35㎖ 트리에틸아민올 90℃에서 식히고 POCI (5㎖, 8.4g, 55mmol)을 6㎖의 에틸렌글리콜디메틸에테르에 녹인 용액을 30분에 걸쳐 서서히 적가하고 그후 15㎖의 얼음물을 넣으면 고체가 얻어진다. 이젖은 고체를 40℃의 벤젠 40㎖에 녹이고 물층을 제거하고 벤젠층을 건조시킨 다음 활성탄소로 60℃에서 5분 교반한 후 고체를 여과시켜 7.5g(80%)의 TOSMIC를 얻는다.Cool it, stir in an ice bath and leave at -20 ° C overnight. The white solid is washed several times with water to give a white solid (mp 106-110 ° C., 45%, 14 g). The resulting tosylmethylformamide (10.7 g, 0.05 mol), 25 mL DME, 10 mL ether, 35 mL triethylamineol was cooled down at 90 DEG C and POCI (5 mL, 8.4 g, 55 mmol) was added to 6 mL of ethylene glycol dimethyl ether. The dissolved solution is slowly added dropwise over 30 minutes and then 15 ml of ice water is added to give a solid. The wet solid is dissolved in 40 ml of benzene at 40 ° C., the water layer is removed, the benzene layer is dried, stirred for 5 minutes at 60 ° C. with activated carbon, and the solid is filtered to obtain 7.5 g (80%) of TOSMIC.

[실시예 2]Example 2

[1-(4-플루오로벤질)-5-[(E) 또는 (Z)-2,6-디메틸-1,5-헵타디에닐] 이미다졸의 합성][Synthesis of 1- (4-fluorobenzyl) -5-[(E) or (Z) -2,6-dimethyl-1,5-heptadienyl] imidazole]

250㎖ 2구 플라스크에 냉각관을 설치하고 질소분위기하에서 시트랄(6.02g, 39.6mmol), 무수 메틸렌 클로라이드 30㎖, 무수 황산 마그네슘 4.76g을 넣은 뒤 주사기로 4-플로우로 벤질아민(4.70㎖, 41.2mmol)을 무수 메틸렌 클로라이드에 녹여 천천히 적가후 약 2시간 동안 환류시킨다. 박막 크로마토그래피로 반응을 확인한 다음 무수 황산 마그네슘을 여과후 제거하고 용매를 감압하에 날려 (E), (Z)혼합물로 위 이민 화합물을 얻는다. (8.92g, 34.6mmol, 87%)Place a cooling tube in a 250 ml two-necked flask, add citral (6.02 g, 39.6 mmol), anhydrous methylene chloride, 30 ml of anhydrous magnesium sulfate and 4.76 g of anhydrous magnesium sulfate under a nitrogen atmosphere, and then use a syringe with 4-flow benzylamine (4.70 ml, 41.2 mmol) is dissolved in anhydrous methylene chloride and slowly added dropwise to reflux for about 2 hours. After confirming the reaction by thin layer chromatography, anhydrous magnesium sulfate was filtered off and the solvent was removed under reduced pressure to obtain the above imine compound as a mixture (E), (Z). (8.92g, 34.6mmol, 87%)

100㎖ 2구 플라스크에 냉각관을 설치하고 이민 화합물(8.92g, 34.6mmol)을 40㎖ MeOH에 녹이고 TOSMIC(10.13g, 51.9mmol)를 넣은 뒤 질소 분위기하에서 t-부틸 아민(10.9ml, 103.8mmol)을 적가깔대기로 천천히 적가후 약 3시간 동안 환류하여 1-(4-플루오로벤질)-5-[(E) 또는 (Z)-2,6-디메틸-1,5-헵타디에닐] 이미다졸 화합물을 얻는다. MeOH을 날리고 에테르로 추출한 후 소금물로 씻고 에테르를 감압하에 제거한 뒤 에틸아세티이트(EA)로 칼럼분리하여 (E), (Z)-화합물을 얻는다.(8.35g, 28.0mmol, 82.4%)Place a cooling tube in a 100 ml two-necked flask, dissolve the imine compound (8.92 g, 34.6 mmol) in 40 ml MeOH, add TOSMIC (10.13 g, 51.9 mmol), and add t-butyl amine (10.9 ml, 103.8 mmol) under a nitrogen atmosphere. ) Is slowly added to the dropping funnel and refluxed for about 3 hours to obtain 1- (4-fluorobenzyl) -5-[(E) or (Z) -2,6-dimethyl-1,5-heptadienyl] imide. Obtains a dazole compound. MeOH was extracted, extracted with ether, washed with brine, ether was removed under reduced pressure, and column separated with ethyl acetate (EA) to obtain (E), (Z) -compound (8.35g, 28.0mmol, 82.4%).

위 화합물은 위치 자리 이성질체로서 분리하지 않는다.The above compounds do not separate as positional site isomers.

(Z):(E)=100:87(Z) :( E) = 100: 87

[실시예 3]Example 3

실시예 2의 4-플루오르벤질아민 대신에 4-클로로벤질아민, 4-메톡시벤질아민 또는 4-트리클로로즈메틸벤질을 사용한다는 것을 제외하고는 실시예 2와 동일한 방법으로 하기 (11) 내지 (16), (19) 및 (20)의 화합물을 제조하였다.In the same manner as in Example 2, except that 4-chlorobenzylamine, 4-methoxybenzylamine or 4-trichlorozmethylbenzyl is used instead of the 4-fluorobenzylamine of Example 2. 16), (19) and (20) were prepared.

에틸 아세테이트: 에테르 (1:2)로 크로마토그래피하여 얻은 각 화합물의 Rf는 다음과 같다;Rf of each compound obtained by chromatography with ethyl acetate: ether (1: 2) is as follows;

(11) 0.46(11) 0.46

(12) 0.35(12) 0.35

(13) 0.33(13) 0.33

(14) 0.22(14) 0.22

(15) 0.37(15) 0.37

(16) 0.27(16) 0.27

(19) 0.40(19) 0.40

(20) 0.30(20) 0.30

[실험예 1]Experimental Example 1

상기 각 실시예에서 합성한 13종의 화합물, 대조화합물로서 KK-42를 4령충의 누에에 경피처리하였다. 즉, 누에 1마리당 각 화합물 5㎍을 녹여 마이크로시린지로 누에 가슴 부위에 도말하였다. 1종의 화합물에 대해 20마리씩 공시하였으며, 처리 30분후에 급상하였고, 그후 1일 3회 급상하여 사육경과를 관찰하고 3면화 잠수를 조사하여 그 활성도를 계산하였다. 결과를 표 1에 나타내었다.KK-42 was percutaneously treated with silkworms of four worms as 13 compounds synthesized in each of the above examples and a control compound. That is, 5 µg of each compound was melted per silkworm and spread on the silkworm chest area with a microsyringe. Twenty animals were reported for one compound, and then spiked 30 minutes after treatment, and then spiked three times a day to observe the breeding progress and to investigate the activity of the three-dive dive. The results are shown in Table 1.

상기 표 1의 결과로부터 알수 있는 바와 같이, 대조인 무처리구와 아세톤 만을 처리한 구는 모두 4면에 들어가 5령 누에가 되었으며, 공시한 kk-42에 의해 3면화된 누에는 75%로 활성이 가장 높았다. 또한 각 실시예에서 합성한 화합물 중에서는 (15)가 70%로 활성이 kk-42에 필적하였다. 한편, (1A)와 (1B)는 각각 35%의 3면화율을 나타내었다.As can be seen from the results of Table 1, the control group and the acetone-only treatment group all entered 4 sides and became 5-year-old silkworms, and the silkworms triangulated by kk-42 showed the highest activity as 75%. . Also, among the compounds synthesized in each example, (15) was 70% and the activity was comparable to kk-42. On the other hand, (1A) and (1B) each exhibited 3% cotton 3%.

[실험예 2]Experimental Example 2

하기 표 2에 나타낸 처방을 이용하되 각종 농도의 KK-42와 본 발명의 화합물을 제제화한 후 농가에서 첨식사육하고 3면화가 100% 달성되는 최저 농도를 결정하였다.Using the formulation shown in Table 2 below, after formulating various concentrations of KK-42 and the compound of the present invention, it was determined that the minimum concentration at which farming and triangulation was achieved 100%.

그 결과, KK-42는 약 20㎍농도에서 100% 3면화가 달성된 반면, 본 발명의 화합물은 약 10㎍의 농도에서 100% 3면화가 달성되었다.As a result, KK-42 achieved 100% tri-cotton at a concentration of about 20 μg, while the compound of the present invention achieved 100% tri-cotton at a concentration of about 10 μg.

따라서, 본 발명의 화합물은 조성물 총 중량당 10-30중량%의 양으로 사용될 수 있다.Accordingly, the compounds of the present invention can be used in amounts of 10-30% by weight per total weight of the composition.

[실시예 3]Example 3

상기 실험예 2와 동일한 처방을 이용하되, 하기 표 3에 나타낸 각 화합물을 10㎍씩 이용하여 제제를 제조한 후, 4령기 누에에 경구 투여하였다.The same prescription as in Experimental Example 2 was used, but the preparations were prepared by using 10 μg of each compound shown in Table 3 below, and then orally administered to the 4th-stage silkworm.

3면화율, 전체 견의 중량, 견충의 중량 및 섬도를 측정하고 결과를 하기 표 3에 나타내었다.Three cotton ratio, the weight of the entire dog, the weight and fineness of the shoulders were measured and the results are shown in Table 3 below.

상기 시험 화합물 중, 1A+1B는 실시예 2에서 얻은 그대로 이성체를 분리하지 않은 혼합물이며, 상기 표 3의 결과로부터 1A+1B의 혼합물로 사용하는 경우 종래 화합물인 KK-42보다 3면화율이 훨씬 높으며, 또한 섬도에 있어서도 훨씬 우수하다는 것을 알 수 있다.Among the test compounds, 1A + 1B is a mixture obtained without separating the isomers as obtained in Example 2, and when used as a mixture of 1A + 1B from the results of Table 3, the three-cotton ratio is much higher than the conventional compound KK-42 It is high and also excellent in fineness.

[실험예 4]Experimental Example 4

실험예 2와 동일한 처방을 이용하되, 단 하기 표4에 나타낸 화합물을 5㎍씩 함유시켜 3령된 누에에 경구 및 경피의 방법으로 투여하고, 3면화율을 측정하였다.The same formulation as in Experimental Example 2 was used, except that the compound shown in Table 4 below was contained 5 ㎍, and then administered to the three-year-old silkworm by oral and transdermal methods, and the three-masking rate was measured.

결과를 하기 표 4에 나타내었다.The results are shown in Table 4 below.

상기 표 4의 결과로부터, 1A 또는 1B 화합물을 단독으로 투여하는 것보다 1A+1B의 혼합물 형태로 투여하는 것이, 그리고 경피 보다는 경구 투여하는 것이 더 효과적임을 알 수 있다. 따라서, 실시예 2에서처럼 이들 화합물을 혼합물의 형태로 얻은 후 이들 이성체를 각각 분리할 필요가 없으므로 비용과 제조공정의 측면에서 유리하고 나아가 활성의 측면에서도 우수한 장점이 있다.From the results in Table 4, it can be seen that it is more effective to administer in the form of a mixture of 1A + 1B than orally administered 1A or 1B compound alone, and oral administration than transdermal. Therefore, it is not necessary to separate each of these isomers after obtaining these compounds in the form of a mixture as in Example 2, which is advantageous in terms of cost and manufacturing process and further has excellent advantages in terms of activity.

[실험예 5]Experimental Example 5

실험예 2와 동일한 처방을 이용하되, 단 1A+1B 혼합물을 3㎍ 배합한 것을 2령, 3령 또는 4령의 누에에게 경피의 방법으로 투여하고, 3면화율, 전체 견의 무게, 견층의 무게, 견층의 비율을 측정하였다. 결과를 하기 표 5에 나타내었다.The same prescription as in Experimental Example 2 was used, except that 3 μg of a mixture of 1A + 1B was administered to the silkworms of 2nd, 3rd, or 4th year by transdermal method, and the percentage of three cotton, the total weight of the dog, Weight and the ratio of the shoulder layer were measured. The results are shown in Table 5 below.

[실험예 6]Experimental Example 6

[본 발명 화합물의 제제화 및 농가 처리 세섬도고치 대량 생산][Formulation of Compound of the Present Invention and Farm Processing Sesumido Kochi Mass Production]

상기 실험예 2와 동일한 처방을 이용하되, 1-(4-플루오로벤질)-5-[(E) 또는 (Z)-2,6-디메틸-1,5-헵타디에닐] 이미다졸의 함량을 20중량%로 하여 수화제를 제조하였다. 이를 이용하여 농가에서 첨식사육한 결과 표 2에서 나타난 바와 같이 춘추기 모두 거의 100%에 가까운 3면화가 유도되었으며 경과일수는 19-20일로 5일 이상 단축되었고 3령 처리시 단견중은 춘기 1.33g, 추기 1.12g으로 평균 纖度 약 1.75d인 고치 생산량(10상자)이 춘기 223.3kg, 추기206kg으로 매우 성공적이었다.Content of 1- (4-fluorobenzyl) -5-[(E) or (Z) -2,6-dimethyl-1,5-heptadienyl] imidazole using the same prescription as in Experimental Example 2 above Was prepared in an amount of 20% by weight. As shown in Table 2, nearly 100% of the three cottons were induced in the spring season, and the number of days was 19-20 days, which was shortened by more than 5 days. In addition, the production of cocoons (10 boxes), which had an average hardness of about 1.75d (1.12g), was very successful at 223.3kg in spring and 206kg in autumn.

한편, 인공 사료육과 뽕잎육의 누에를 상대로 하여 1A, 1B 또는 1A+1B 혼합물을 투여하여 비교한 결과는, 인공 사료육보다 뽕잎육의 경우에, 그리고 1A, 1B단독 보다는 1A+1B혼합물의 경우에 3면화율의 활성이 높게 나타났다.On the other hand, the results of comparing 1A, 1B or 1A + 1B mixtures to silkworms of artificial feed meat and mulberry leaf meat were compared with that of mulberry leaf meat than artificial feed meat and 1A + 1B mixture rather than 1A and 1B alone. The activity of 3 cotton rate was high.

이상의 결과를 종합할 때, 뽕잎육의 경우에 3령 1-2일 째에 누에 1마리당 본 발명의 화합물을 10-20㎍의 농도로 희석한 수용액을 뽕잎에 분무한 후 3회 하루동안 급여하면 목적으로 하는 2.0d 정도 굵기의 고치실을 생산할 수 있을 것으로 판단된다. 그리고, 본 발명 화합물에 대한 3면화율의 활성은 춘기보다는 추기에 활성이 높았다. 그리고, 본 발명의 화합물을 투여하는 시기를 3령에서 4령으로 늦추면 보다 섬도가 높은 고섬도의 실을 얻을 수 있다.To summarize the above results, in the case of mulberry leaf meat when spraying the mulberry leaf three times a day after spraying the aqueous solution diluted 10-20 ㎍ of the compound of the present invention per silkworm on the 3rd 1-2 days It is expected to be able to produce cocoons of about 2.0d in thickness. In addition, the activity of the trivalent cotton with respect to the compound of the present invention was higher in the autumn than in the spring. In addition, when the time of administering the compound of the present invention is delayed from 3 to 4, high fine thread can be obtained.

Claims (4)

하기 일반식(3)의 화합물과 하기 일반식(4)의 화합물을 반응시켜 하기 일반식(5)의 화합물을 수득하고, 이어 일반식(5)의 화합물을 하기 일반식(2)의 화합물과 반응시켜 하기 일반식(1A)의 화합물(E-형태)과 하기 일반식(1B)의 화합물(Z-형태)의 혼합물의 형태로서 1-(4-플루오로벤질)-5-[-2,6-디메틸-1,5-헵타디에닐]이미다졸을 수득함을 특징으로 하는 1-(4-플루오로벤질)-5-[(E) 또는 (Z)-2,6-디메틸-1,5-헵타디에닐]이미다졸의 제조방법.The compound of formula (3) is reacted with the compound of formula (4) to obtain a compound of formula (5), and the compound of formula (5) is then reacted with the compound of formula (2) 1- (4-fluorobenzyl) -5-[-2, in the form of a mixture of a compound of formula (1A) (E-form) and a compound of formula (1B) (Z-form) 1- (4-fluorobenzyl) -5-[(E) or (Z) -2,6-dimethyl-1, characterized in that 6-dimethyl-1,5-heptadienyl] imidazole is obtained. Method for preparing 5-heptadienyl] imidazole. 1-(4-플루오로벤질)-5-[(E)-2,6-디메틸-1,5-헵타디에닐]이미다졸(1A)과 1-(4-플루오로벤질)-5-[(Z)-2,6-디메틸-1,5-헵타디에닐]이미다졸(1B)의 혼합물을 유효성분으로서 함유함을 특징으로 하는 누에를 3면화(眠化)하기 위한 생리활성 조절제 조성물.1- (4-fluorobenzyl) -5-[(E) -2,6-dimethyl-1,5-heptadienyl] imidazole (1A) and 1- (4-fluorobenzyl) -5- [ (Z) -2,6-dimethyl-1,5-heptadienyl] imidazole (1B) containing a mixture of the active ingredient, a bioactive regulator composition for triangulating silkworms. 제2항에 있어서, 상기 (1A)와 (1B)의 혼합물이 10∼20중량%의 양으로 함유됨을 특징으로 하는 조성물.The composition according to claim 2, wherein the mixture of (1A) and (1B) is contained in an amount of 10 to 20% by weight. 제2항의 조성물을 3령 또는 4령의 누에에 경구 투여함을 특징으로 하는 누에를 조기변태시켜 3면화를 유도하는 방법.A method of inducing tricot by premature transformation of silkworms, characterized by orally administering the composition of claim 2 to 3 or 4 silkworms.
KR1019950010135A 1995-04-27 1995-04-27 Silkworm bioactivity regulator KR0173436B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019950010135A KR0173436B1 (en) 1995-04-27 1995-04-27 Silkworm bioactivity regulator

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019950010135A KR0173436B1 (en) 1995-04-27 1995-04-27 Silkworm bioactivity regulator

Publications (2)

Publication Number Publication Date
KR960037661A KR960037661A (en) 1996-11-19
KR0173436B1 true KR0173436B1 (en) 1999-02-01

Family

ID=19413117

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950010135A KR0173436B1 (en) 1995-04-27 1995-04-27 Silkworm bioactivity regulator

Country Status (1)

Country Link
KR (1) KR0173436B1 (en)

Also Published As

Publication number Publication date
KR960037661A (en) 1996-11-19

Similar Documents

Publication Publication Date Title
DE69231798T3 (en) 1-Biphenylimidazolderivate, process for their preparation and their therapeutic use
US7915303B2 (en) Glycopyrronium salts and their therapeutic use
EP0315574A2 (en) Renin inhibitors
EP0354522A1 (en) Use of alpha-aminoboronic acid derivatives in prevention and treatement of viral diseases
DE3840452A1 (en) (BETA) -amino-boronic acid DERIVATIVES
US4254107A (en) Long-lasting agonists of enkephalin
EP0035393A1 (en) Poultry feeds containing and methods of using anovulatory compounds, and novel anovulatory imidazolines
CA2067282A1 (en) Pesticidal 1-aryl-5-(substituted alkylideneimino)-pyrazoles
DE1958201A1 (en) New substituted N-allyl-2-arylamino-imidazoline- (2) and processes for their preparation
US5395957A (en) Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in pharmaceutical compositions and animal feeds
DE60222286T2 (en) PROCESS FOR INCREASING THE TESTOSTERONE MIRROR
HU190608B (en) Process for preparing 3-phenoxy-1-azetidine-carboxamide derivatives
KR0173436B1 (en) Silkworm bioactivity regulator
JPS58128380A (en) Novel imidazole compounds, manufacture and anti-epizoon
CA2474627C (en) R-(-)-1-[2-(7-chlorobenzo[b]thiophen-3-yl-methoxy)-2-(2,4-dichlorophenyl)-ethyl]-1h-imidazole
JP2003525275A (en) 3-thiomethylpyrazole as a pesticide
US3998953A (en) 1,3,7-Trisubstitued xanthine peripheral vasodilators
DE3438244C2 (en)
EP0668874A1 (en) Lhrh antagonists and intermediate products
JPS6348266A (en) Heteroarylethylamine, its production and its use as livestock production promoter
US4524152A (en) 1-Cyano-3-(fluoroalkyl)guanidines for lowering blood pressure
DE3017026C2 (en) Isoprenylamines and their acid addition salts and antiviral agents for vertebrates containing them
US6015925A (en) Antifungal agents
JPH01500429A (en) Benzopyran and benzothiopyran derivatives, compositions containing the compounds, methods for producing the same, and intermediates thereof
DE2259012C3 (en) 8beta-Pvrimidyl- (2) -aminomethyl-10a-ergoline derivatives and process for their preparation

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
J201 Request for trial against refusal decision
B701 Decision to grant
GRNT Written decision to grant
EXPY Expiration of term